Additional file 1 of Post-marketing safety profile of ganirelix in women: a 20-year pharmacovigilance analysis of global adverse drug event databases (2004–2024)
收藏Figshare2025-04-23 更新2026-04-08 收录
下载链接：
https://springernature.figshare.com/articles/dataset/Additional_file_1_of_Post-marketing_safety_profile_of_ganirelix_in_women_a_20-year_pharmacovigilance_analysis_of_global_adverse_drug_event_databases_2004_2024_/28845608/1
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Material Table S1: The 65 PT entries that simultaneously satisfied the four methods of disproportionality analysis with positive signal strength in FAERS. The PT entries are categorized into three groups: expected with signal (unmarked), disease-expected (marked with +), and unexpected (marked with *), and are listed in descending order of case number.
提供机构：
Zou, Fan; Cui, Zhiwei; Wu, Xiaoling; Feng, Xiaoshan; Yang, Yang
创建时间：
2025-04-23
